Crossmark

Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1136/rmdopen-2015-000134

Published Online: 2015-08-13

Published Print: 2015-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Alten, Rieke

Grahn, Amy

Holt, Robert J

Rice, Patricia

Buttgereit, Frank
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct00650078 at ClinicalTrials.gov

Documents that mention this clinical trial

Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis
https://doi.org/10.1136/rmdopen-2015-000134

nct00650078 at ClinicalTrials.gov

Documents that mention this clinical trial

Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis
https://doi.org/10.1136/rmdopen-2015-000134

Document is current

Any future updates will be listed below